A Phase I/IIa Study to Evaluate the Safety, Tolerability and Efficacy of Topical LTX-109 in Subjects Nasally Colonized With Methicillin-resistant/-Sensitive Staphylococcus Aureus (MRSA/MSSA)
Clinical trial NCT01158235 · COMPLETED
Trial details
- NCT number
- NCT01158235
- Sponsor
- Lytix Biopharma AS
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2011-04-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.